• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ARCHITECT ANTI-HCV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ARCHITECT ANTI-HCV Back to Search Results
Catalog Number 06C37-74
Device Problem False Negative Result (1225)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 07/07/2020
Event Type  malfunction  
Manufacturer Narrative
Patient identifier = (b)(6).This report is being filed on an international product, list number 6c37 that has a similar product distributed in the us, list number 1l79.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.There was no additional patient information provided by the customer.
 
Event Description
The customer reported false nonreactive architect anti-hcv results on a (b)(6) pregnant patient.The patient was waiting for surgery in the emergency department.The patient sample was drawn on (b)(6) 2020, however, since the anti-hcv assay was not calibrated on the architect, the sample was not tested until (b)(6) 2020.The results provided were: on (b)(6) 2020 the maccura instrument = (b)(6); on (b)(6) 2020 (b)(6) architect = (b)(6).There were no other tests performed to determine which result was correct.The patient had delayed surgery (unknown what type) while waiting for the architect results.There was no actual adverse impact to the patient reported.
 
Manufacturer Narrative
Correction to section d suspect medical device, 4.Catalog # from 06c37-27 to correct 06c37-74, lot # from 11370be00 to correct 11370be03, and udi from (b)(4).
 
Manufacturer Narrative
The complaint investigation for fa alse non-reactive result for one patient tested with the architect anti-hcv assay included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review and inhouse testing of retained kits of lot 11370be00.Lots 11370be00 and 11370be03 contain the same bulk material and are identical except the labeling of the outer package.Return testing was not completed as returns were not available.Trending review determined no trends for the issue for the product.Device history record review did not identify any non-conformances or deviations with the lot and complaint issue.A review of the product labeling concluded that the issue is sufficiently addressed.In house testing of two commercially available seroconversion panels (zeptometrix hcv 9047 and hcv 9045) was performed with the lot.The seroconversion panel results were compared to historical architect hcv test results provided by zeptometrix.The reagent detected the same bleeds as reactive with comparable s/co values for the seroconversion panels.Based on these data, it was shown that the sensitivity performance of the lot is not negatively affected.Based on the investigation, no systemic issue or deficiency with the architect anti-hcv reagent, lot 11370be03 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT ANTI-HCV
Type of Device
ANTI-HCV
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key10326243
MDR Text Key222162358
Report Number3002809144-2020-00732
Device Sequence Number1
Product Code MZO
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup,Followup
Report Date 09/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/10/2020
Device Catalogue Number06C37-74
Device Lot Number11370BE03
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/06/2020
Initial Date FDA Received07/27/2020
Supplement Dates Manufacturer Received08/11/2020
09/09/2020
Supplement Dates FDA Received08/31/2020
09/09/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR ANALYZER, LN 03M74-01,; ARCHITECT I2000SR ANALYZER, LN 03M74-01,; ARCHITECT I2000SR ANALYZER, LN 03M74-01,; SERIAL # (B)(6) ; SERIAL # (B)(6) ; SERIAL # (B)(6)
Patient Age29 YR
-
-